Gut microbiota in infants with food protein enterocolitis
Pediatric Research · 2025
DOI: 10.1038/s41390-024-03424-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Research, 2025. Verfasst von Jing Xiong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Enterocolitis, Infant Formula, Dietary Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: We explored the effects of two formulas, extensively hydrolyzed formula (EHF) and amino acid-based formula (AAF), on the gut microbiota and short-chain fatty acids (SCFAs) in infants with food protein-induced enterocolitis syndrome (FPIES). METHODS: Fecal samples of thirty infants with bloody diarrhea receiving EHF or AAF feeding were collected at enrollment, diagnosis of FPIES, and four weeks after diagnosis. The gut microbiota and SCFAs were analyzed using 16 S rRNA gene sequencing and gas chromatography-mass spectrometry, respectively. RESULTS: Microbial diversity of FPIES infants was significantly different from that of the controls. FPIES infants had a significantly lower abundance of Bifidobacterium and a higher level of hexanoic acid compared with controls. In EHF-fed FPIES infants, microbial richness was significantly decreased over time; while the microbial diversity and richness in AAF-fed FPIES infants exhibited no differences at the three time points. By four weeks after diagnosis, EHF-fed FPIES infants contained a decreased abundance of Acinetobacter, whereas AAF-fed FPIES infants contained an increased abundance of Escherichia-Shigella. EHF-fed infants experienced significantly decreased levels of butyric acid and hexanoic acid at four weeks after diagnosis. CONCLUSIONS: Infants with FPIES had intestinal dysbiosis and different formulas differentially affected gut microbiota and SCFAs in FPIES infants. IMPACT: We firstly report the impacts of two different nutritional milk formulas on the gut microbial composition and SCFAs levels in infants with FPIES. We show that infants with FPIES have obvious intestinal dysbiosis and different formulas differentially affect gut microbiota and SCFAs in FPIES infants. Understanding the effects of different types of formulas on gut microbial colonization and composition, as well as the related metabolites in infants with FPIES could help provide valuable insights for making choices about feeding practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, China.
- Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
- National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
- China International Science and Technology Cooperation base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
- Department of Neonatology, The first People's Hospital of Jiulongpo District, Chongqing, China.
Zitieren
APA
Xiong, J., Ma, Y. J., Liao, X. S., Li, L. Q., & Bao, L. (2025). Gut microbiota in infants with food protein enterocolitis. Pediatric Research. https://doi.org/10.1038/s41390-024-03424-9
Vancouver
Xiong J, Ma YJ, Liao XS, Li LQ, Bao L. Gut microbiota in infants with food protein enterocolitis. Pediatric Research. 2025. doi:10.1038/s41390-024-03424-9
BibTeX
@article{Xiong2025,
author = {Xiong, Jing and Ma, Yu-Jue and Liao, Xing-Sheng and Li, Lu-Quan and Bao, Lei},
title = {Gut microbiota in infants with food protein enterocolitis},
journal = {Pediatric Research},
year = {2025},
doi = {10.1038/s41390-024-03424-9}
}
EUVIMED